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ABSTRACT 
 
From Cellular Transport to Synthetic Biomimetic Transport 





One of the many interesting materials that have emerged in the field of nanotechnology in 
the last quarter century is Carbon Nanotube (CNT). CNTs have been explored in a broad 
range of fields from electronic devices and biosensors, to bioimaging and tissue 
engineering. However, as stand-alone materials CNTs have limited capabilities in the 
field of biology and medicine unless they are combined with biological agents. Due to the 
similarity in diameters, CNTs can be combined with biomolecules such as enzymes, 
antibodies, antigens, DNA, etc. These “hybrid” assemblies will combine the properties of 
the CNTs with the recognition characteristics and functions of the biomolecules.  
 
In our work we utilize one such biomolecule – actin, which is present in almost all 
eukaryotic cells and serves as scaffold for molecular motor myosin. The results of the 
research indicate that actin monomers (G-actins) were able to attach to Multi-Walled 
Carbon Nanotubes (MWCNTs). The MWCNTs exhibited close to full coverage by the G-
actin proteins. Moreover, the G-actins remained functional and were able to polymerize 
into actin filaments (F-actin) onto the MWCNT scaffolds. Furthermore, the functionality 
of actin filaments on the surface of the MWCNTs was also investigated. The CNT-F-
actin hybrid assemblies showed limited movement in synthetic environment. This may be 
partially due to the inability of the myosin motors to recognize the polarity of the actin 
filaments, or due to steric hindrance and orientation of actin-based hybrids. The results of 
our work indicate that these hybrid assemblies can be useful for future biosensor 
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Chapter 1 Introduction 
1.1 What is Nanotechnolgy? 
Nanotechnology is defined as: “science, engineering, and technology conducted at the 
nanoscale, which is about 1 to 100 nanometers” [1]. One nanometer is a billionth of a meter (10-9 
of a meter).  Figure 1.1 shows various objects using a nanometer scale. 
 
 
Figure 1.1 - Nanometer Scale, National Institutes of Health (NIH) 
 
The concept of nanotechnology has been around for at least 50 years, with its basic 
principles and concepts being described by Richard Feynman in his seminal talk titled “There’s 
Plenty of Room at the Bottom” at the California Institute of Technology in 1959. During this talk 
Feynman discussed the manipulation of materials at the atomic-level. Norio Taniguchi first 
introduced the term nanotechnology in 1974, in a paper titled “On the basic concept of 
nanotechnology” [2].  
Today nanotechnology is being investigated in a variety of fields ranging from 
electronics [3] and energy [4] to medicine [5], food safety [6] and transportation [7]. For instance 
in medicine, nanotechnology may be utilized in the future for cancer therapy and diagnostic 
techniques as well as drug delivery and tissue engineering [8].  In electronics, nanoscale 
transistors have been made that are faster and more energy efficient when compared to their 
traditional counterparts [1].  
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One of the more interesting materials emerging in the field of nanotechnology is Carbon 
Nanotube (CNT).  CNTs are hollow cylinders made of carbon atoms. Two main forms of CNTs 
are - Single-Walled Carbon Nanotubes (SWCNTs), which consist of a single graphene sheet and 
Multi-Walled Carbon Nanotubes (MWCNTs), which are made of multiple layers of graphene 
sheets [9,10]. A typical SWCNT is shown in Figure 1.2.   
 
 
Figure 1.2 - Single-Walled Carbon Nanotube 
 
As stand-alone materials CNTs have limited abilities in the field of biology and medicine 
unless combined with other biological agents. Combining nanomaterials, such as CNTs, with 
biomolecules (such as enzymes, antibodies/antigens/DNA) can lead to the creation of hybrid 
assemblies, which combines both the recognition abilities and function of the biomolecules along 
with the properties of the CNTs [11].  
Another emerging area of research in the field of nanotechnology has been investigating 
transportation of biomolecules and nanoparticles in vitro through the use of molecular motors 
[12]. Motor proteins, such as kinesin and myosin and their associated filaments (microtubule and 
actin filaments), have been used in a variety of applications for the purpose of sorting [13], 
detection [14], and transportation [15,16]. Motor proteins and their filaments have been used 
along with Adenosine Triphosphate (ATP) as the energy source to create miniaturized and 
integrated devices; without the use of external pumps and energy sources in replacement of 




1.2 Motivation and Proposed Work 
In this research actin was utilized in conjunction with CNTs to develop functional hybrid 
assemblies. Actin is present in almost all eukaryotic cells and serves as scaffold for molecular 
motor myosin.  
One of the purposes of this research includes analyzing the behavior and functionality of 
actin monomers when immobilized onto CNTs when compared with free G-actin in solution.  In 
the cell G-actin polymerizes to F-actin, a major component of the cellular cytoskeleton [20]. If 
the immobilized G-actin is still functional, then addition of extra free G-actin will lead to 
polymer-based structure onto MWCNTs scaffolds.  
Another goal was to investigate the functionality of the CNT-F-actin.  Recognition of 
actin filaments on the surface as well as motility of these proposed hybrids were tested using 
myosin and ATP in a gliding motility assay. Myosin is one of the motor proteins present in the 
cell that converts chemical energy to mechanical movement through hydrolysis of ATP. Actin-
myosin assemblies participate in many cellular processes from contraction to cell motility and 
division [20]. Creating functional hybrid assemblies may facilitate possible solutions for 
transportation of biological and non-biological samples to specific locations in vitro.  
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1.3 Organization of this Thesis 
The thesis presented herein is organized as follows: 
 
• Chapter 2: provides an overview of the background knowledge that is essential to 
understanding this work.  In particular, an overview of CNTs, actin, myosin, streptavidin, 
and biotin is provided.  
 
• Chapter 3: provides a closer look at the current state of the art in CNT and protein based 
system and their applications.   
 
• Chapter 4: presents the experiments conducted in this research. This provides the 
foundation that was used to investigate the properties of CNT and actin-CNT hybrid 
assemblies.  
 
• Chapter 5: provides an overview of the materials and methods that were required to 
conduct the experiments described in Chapter 4.  
 
• Chapter 6: provides the results and conclusions obtained upon performing each of the 
experiments in Chapter 4. 
 
• Chapter 7: provides the concluding remarks and presents potential areas of future work.  
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Chapter 2 Background 
2.1 Carbon Nanotubes 
2.1.1 Carbon Nanotube History and Properties 
Carbon Nanotubes (CNTs) are hollow cylinders made of carbon atoms. Sumio Iijima 
discovered MWCNTs in 1991. In 1993, Iijima and Ichihashi from Nippon Electric Company 
(NEC) as well as Bethune et al. from IBM independently published on the formation of single-
walled carbon nanotubes [21]. Figure 2.1 shows a typical single-walled carbon nanotube on the 
left and a multi-walled carbon nanotube on the right.   
 
 
Figure 2.1 - Single-walled on the left and Multi-walled carbon nanotube on the right [22] 
 
SWCNTs have diameters of 0.4-2 nm, while MWCNTS have multiple layers of graphene 
that results in a larger diameter ranging from 2 to 100 nm with lengths from nanometer to 
centimeters. The optical characteristics of SWCNTs provide better optical absorption and can be 
effective as biological imaging, while MWCNTs can be used to effectively transport larger 
biomolecules [9].  
CNTs are nanomaterials with unique properties, for example large surface area, high 
electrical conductivity, chemical stability and mechanical strength that make them applicable in 
electronics [23-27], biosensors [28-30], drug delivery [31,32], tissue engineering [33], 




2.1.2 Carbon Nanotube Functionalization  
Carbon nanotubes have highly hydrophobic surfaces, which limits their dispersion in 
aqueous solutions. Surface chemistry modification or functionalization is used to increase 
dispersity in biological and biomedical applications.  Functionalization of carbon nanotubes can 
be done using covalent or non-covalent approaches based on the desired applications [36].  
2.1.2.1 Covalent functionalization of carbon nanotubes 
One of the most commonly used methods for covalent functionalization involves 
oxidation of CNTs using acid oxidizing agents such as nitric and sulfuric acids. This process 
enables formation of carboxyl groups onto the nanotube ends and at the defects site on their 
sidewalls. Oxidation increases carbon nanotubes solubility and also attachment of biomolecules 
such as proteins and DNAs via covalent binding for various applications [36].  However, such 
process can significantly influence the structure and properties of carbon nanotubes [39].  
Another method for covalent functionalization that increases sidewall functionalization is 
cycloaddition reaction. Figure 2.2 and 2.3 illustrate covalent functionalization of carbon 
nanotubes using oxidation and cycloaddition of CNTs respectively [10]. 
 
 
Figure 2.2 - Carbon nanotube oxidation [10] 
 
Figure 2.3 - [2+1] cycloaddion of carbon nanotube [10] 
 
2.1.2.2 Non-covalent functionalization 
Different non-covalent functionalization approaches include: coating carbon nanotubes 
with surfactants, polymers and biomolecules through van der Waals forces, hydrophobic 
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interactions and π-π stacking [40]. As an example, polyethylene glycol (PEG) can be used for 
non-covalent coating and also prevention of non-specific protein binding [39].  
Commercial availability and low cost of surfactants has made them interesting solutions 
for functionalization of carbon nanotubes. Generally, polymers have the advantage of robust 
surface adsorption over surfactants. Hydrophobic interactions of carbon nanotubes can dominate 
adsorption of polymers, and therefore affect the dispersion efficiency [36]. Figure 2.4 illustrates 
non-covalent attachment of single-stranded DNA on SWCNT through π-π stacking. 
 
 
Figure 2.4 - Non-covalent coating of SWCNT with DNA [41] 
 
Advantages of covalent functionalization include robustness when compared to non-
covalent functionalization; however excessive oxidation can influence the structure and 
properties of the carbon nanotubes such as photoluminescence and Raman scattering [10].    
Unlike in covalent functionalization, the physical properties and structure of CNTs are 
not affected by physical functionalization. However, based on the application, non-specific 
binding and denaturation of the attached target biomolecule may be some of the disadvantages 
[42].  
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2.1.2.3 Carbon nanotube-based encapsulation  
 
Figure 2.5 - Carbon nanotubes encapsulating drugs and fullerene [44] 
 
Encapsulation of materials inside carbon nanotubes has been investigated for applications 
ranging from storage of liquids and materials, to drug delivery, or nanowires, etc [43]. Some of 
the materials investigated include liquids [45], biomolecules such as DNA [46] and protein [47], 
fullerene derivatives [48] and organics [49]. One of the advantages of encapsulating materials 
inside CNTs is protection and control delivery to specific and desired locations [50]. Figure 2.5 
illustrates encapsulation of an anticancer drug and C60 fullerenes to seal the carbon nanotubes 













2.2 Structure and Function of Actin and Myosin 
The cytoskeleton consists of three cytoskeletal filaments: actin filaments, microtubules 
and intermediate filaments. These protein filaments are involved with many activities including 
the shape and movement of the cell, muscle contraction, and intracellular transport of organelles. 
Motor proteins are molecular motors that move along cytoskeletal filaments by converting 
chemical energy to mechanical movement through hydrolysis of ATP. For example myosin and 
kinesin motor proteins bind to and interact with actin filaments and microtubules respectively 
[20].  
2.2.1 Actin Filaments 
Actin is highly conserved protein present in almost all eukaryotic cells and serves as 
scaffold for myosin molecular motors. Actin filaments consist of double stranded helical 
arrangement of actin molecules (Globular actin or G-actin) with diameters from 7 to 9 nm. They 
are polar structures with a plus and a minus end. The minus end also called “pointed end” is the 
slow growing side and the plus end or “barbed end” is the faster growing side. This means the 
barbed end polymerizes faster to form the F-actin than the pointed end [20]. Figure 2.6 on the 
left illustrates the arrangement of actin molecules (G-actin) in an actin filament (F-actin) with the 
structure repeating every 37 nanometers. The figure on the right is a three-dimensional model of 
an actin molecule using X-ray diffraction. 
 
Figure 2.6 - Left: Actin filament, Right: Actin molecule, yellow represents a single molecule of ATP [20] 
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Polymerization of actin molecules to actin filaments in vitro occurs by addition of K+ and 
Mg2+ in the presence of ATP. The polymerization rate at the barbed end is up to 10 times faster 
than the pointed end. The critical concentration (Cc) is an important factor in the polymerization 
process. At the Cc value, concentration of actin monomers is in equilibrium with actin filaments. 
This value is around 0.1 µM for in vitro conditions and enables polymerization when G-actin 
concentration is above this value. Depolymerization of F-actin occurs below the critical 
concentration. After polymerization ATP is hydrolyzed to Adenosine Diphosphate (ADP) and 
trapped inside the actin filament until depolymerization occurs [20, 51].  Figure 2.7 illustrates the 
ATP hydrolysis procedure at the actin site. 
 
 
Figure 2.7 - ATP hydrolysis at the actin site [20] 
 
The dynamic behavior of actin filaments in cells has been investigated using drugs that 
stabilize or destabilize F-actin. Cytochalasins are fungal products that attach to the barbed end 
and prevent polymerization while phalloidin toxins from Amanita mushroom bind along actin 
filaments to prevent depolymerization. Fluorescent derivatives of phalloidin can be used to 
observe actin filaments using fluorescent microscopy [20]. 
2.2.2 Myosin Motor Proteins 
Myosin motor proteins are a class of molecular motors that recognizes and bind to the 
actin filaments. Myosin proteins convert chemical energy from ATP hydrolysis to mechanical 
work and produce the required energy for movement of actin filaments. Almost all myosin 
motors move along actin filaments from the minus end towards the plus end. Myosin-I and 
Myosin-II are the most studied myosin proteins as they are present in almost all eukaryotic cells 
[51].  
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Muscle myosin is one of the subfamilies of myosin (Myosin-II). Myosin-II is responsible 
for muscle contraction and cytokinesis and consists of two heavy chains and four light chains. 
Each of the two heavy chains has a head domain with an ATPase and actin binding site, a neck 
domain that light chains bind to, and a tail domain. The amino side is called the N terminus, 
which is the motor domain, and the carboxyl side is named the C terminus [20]. Figure 2.8 
depicts myosin-II.  
 
Figure 2.8 - Myosin-II [20] 
 
Non-muscle cells contain smaller myosin motors including Myosin-I. Myosin-I is 
involved in cytoskeleton-membrane interactions including transportation of membrane vesicles. 
Depending on the tail of myosin motors, they can move vesicles or actin filaments [20]. Figure 
2.9 shows the different roles of Myosin-I and Myosin-II. 
  
 





Heavy MeroMyosin (HMM) 
Myosin-II can be cleaved into Heavy Meromyosin (HMM) and Light Meromyosin 
(LMM) using α-chymotrypsin. HMM consists of head domains, light chains and part of the 
coiled-coil tail [52]. Figure 2.10 shows a diagram of myosin-II: 
 
Figure 2.10 - Myosin diagram [52] 
 
In work by Guo and Guilford [53] motility of mysoin-II was compared to HMM and 
subfragment-1 for in vitro applications. The authors mention that results of motility assays have 
indicated a higher velocity for HMM-coated surface and lower velocity on subfragment-1 when 
compared to myosin. Unknown interactions between myosin and actin filaments may cause the 
observed slower movement of the filaments. Also, interaction of mysoin with nitrocellulose-
coated surfaces for in vitro motility assays may cause denaturation of the tail and results in non-
native interactions between actin filaments and myosin. The authors further investigated effects 
of low ionic strength of solutions for in vitro motility assays on actin interaction with the tail 
domain (LMM). The results indicate that increasing the ionic strength to achieve ionic strengths 
close to physiological conditions, decreased the difference between velocities of HMM and 
HMM/LMM mixture [53].    
2.2.3 Actin-myosin interaction 
Actin-myosin assemblies participate in many cellular processes from contraction to cell 
motility and division. In the first step of actin movement, a myosin head binds tightly to an actin 
filament. This state ends rapidly by attachment of an ATP molecule. The binding of ATP reduces 
the affinity of the myosin head and allows movement along the filament [20].  Figure 2.11 




Figure 2.11 - Attachment of myosin and movement along actin [20] 
 
Next, through ATP hydrolysis ADP and Pi are produced but remain attached to the 
myosin head. The myosin head is displaced along the filament, this new weak binding causes Pi 
to get released and also causes a power stroke. The power stroke releases ADP resulting in the 
myosin head binding tightly to the actin filament and returning to the start of a new cycle [20].  
Figure 2.12 depicts these steps: 
 
Figure 2.12 - Displacement of myosin along actin [20] 
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2.3 Structure and Function of Primary and Secondary Antibodies 
Antibodies (Ab) are proteins produced by the immune system to detect and neutralize 
foreign and harmful targets. These large Y-shaped proteins recognize antigens (a unique part of 
the targets) through the antigen binding sites [54]. Figure 2.13 shows the interaction between an 
antibody and antigens. 
 
 
Figure 2.13 - Antibody and antigens, Wikimedia Common 
 
Antibodies contain two identical heavy chains and two identical light chains that are 
connected through disulfide bonds. The class of an antibody is based on the type of heavy chains 
present in that antibody [54]. Figure 2.14 illustrates the structure of an antibody: 
 
Figure 2.14 - Structure of an antibody, Wikimedia Commons 
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Antibodies can be used in different bionanotechnology applications to detect a specific 
antigen. The two methods of detection include direct and indirect detections. Direct detection 
involves using a primary antibody that binds to a specific antigen. However, primary antibodies 
are usually unlabelled. Secondary antibodies labeled with probes can bind to primary antibodies 
or primary antibody fragments for indirect detection.  
Secondary antibodies used for indirect detection offer advantages compared to labeled 
primary antibodies. Binding of several secondary antibodies to a primary antibody increases 
sensitivity through signal amplification; also secondary antibodies can bind to primary antibodies 
of the same isotype whereas primary antibodies bind to specific antigens with the same 




Figure 2.15 - Primary and secondary antibodies, Wikimedia Commons 
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2.4 Structure and Function of Streptavidin and Biotin 
 
Figure 2.16 - Streptavidin (ribbon) bound to biotin (sphere), Wikimedia Common 
 
Streptavidin, a protein isolated from bacterium Streptomyces avidinii, is a tetrameric 
protein that has four binding sites with a high binding affinity (dissociation constant Kd =10-15 
mol/L) for biotin (a water soluble B-vitamin present in every living cell, vitamin B7). The 
binding of streptavidin and biotin is one of the strongest non-covalent interactions and is heavily 
used in biotechnology and diagnostic applications [56]. Figure 2.16 illustrates the streptavidin-
biotin interaction. Streptavidin-biotin interactions enable specific detection of the target of 
interest by functionalization of the target with biotin, which does not usually affect the biological 
activity of the target. Further, the bond is stable against pH and temperature changes, organic 
solvents and detergents [57]. 
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Chapter 3 Related Work 
In this section the current state of the art in CNT and protein based systems is described 
in detail.  
3.1 Carbon Nanotube- Microtubule Hybrid Assemblies 
Prior research in creating protein/CNT hybrid assemblies has focused on the use of 
microtubules [58].  In [58] combination of CNTs with tubulin created microtubule morphologies 
that would not be possible without the presence of the MWCNTs. AFM analysis of the tubulin-
MWCNT conjugates shows the creation of different patterns based on varying concentration of 
tubulin. Tubulin was also polymerized on the surface along the axis of MWCNTs and the 
nanotubes were encapsulated by the resulting microtubules. Figures 3.1 shows the Transmission 
Electron Microscopy (TEM) images of microtubule-MWCNT hybrids (a) and MWCNTs 
controls (b) . 
 
 
Figure 3.1 - TEM images of a) Microtubule-MWCNTs b) MWCNTS without tubulin [58] 
 
The motility of microtubule-MWCNT biohybrids was examined on kinesin motor 
proteins-coated surfaces using the gliding motility assay. Briefly, in the gliding assay, the motors 
are fixed on the surface and in the presence of ATP the filaments glide on the kinesin-coated 
surface. The biohybrids showed sideway motions through fluctuation and translocation on 
kinesin motors. The irregular motions of microtubule-MWCNTs could have resulted from 
different polarity of biohybrids when compared to individual microtubules. Figure 3.2 compares 




Figure 3.2 - Schematic of microtubule vs. microtubule-MWCNT biohybrid motility [58] 
 
In [59], the authors investigated hybrid formation using biotinylated microtubules and 
streptavidin-MWCNT conjugates through strong and specific interaction between streptavidin 
and biotin. AFM analysis of MWCNT coated with streptavidin indicated uniform coverage of 
streptavidin on the surface of the nanotubes. Hybrid assemblies were then formed by incubation 
of streptavidin-MWCNT conjugates with biotinylated microtubules. The streptavidin-MWCNT 
and biotinylated microtubules hybrids were analyzed using TEM. The analyses revealed that the 
nanotubes were either in parallel and linear orientation, or bent and attached through their bent 
regions with the microtubules to form the biohybrids. The investigation of the motility assay 
using kinesin-coated surface resulted in gliding of the hybrid assemblies, therefore indicating the 
attachment of microtubles to MWCNTs did not interfere with kinesin affinity for microtubules. 




Figure 3.3 - Streptavidin-coated MWCNT and biotinylated microtubule hybrid [59] 
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3.2 In Vitro Sliding of Actin Labeled Quantum dots 
Actomyosin motility assays for transportation of cargo in nanotechnological applications is 
another open area of research for hybrid motility. The ability to transport quantum dots was 
investigated using streptavidin-coated CdSe quantum dots (Qdots) and biotinylated actin 
filaments. The results showed that there was no significant difference between velocity of actin-
quantum dots and individual actin filaments. Labeling filaments with Qdots enables location 
tracking of cargo in nanotechnological applications due to high stability of Qdots against 
photobleaching [60].  
 
3.3 Transportation of Cargo using Actin Bundles  
One approach in using actin filaments for transport of cargo on motor patterned surfaces 
in synthetic environment is creating actin bundles [61]. The researchers investigated 
transportation of cargo such as liposomes and single cells (Escherichia coli) using actin bundles 
and myosin motor proteins [62]. Liposomes were chosen due to their ability to encapsulate and 
transport molecules for nanotechnology applications, and E. coli was used based on its ability to 
produce proteins. Neutravidin was also used to link and attach the biotinylated liposome and E. 
coli to labeled actin bundles. Figure 3.4 shows the attachment of cargoes to actin bundles.  
 
 




Figure 3.5 confirms attachment of a liposome to actin bundles using TEM. 
 
 
Figure 3.5 - Transmission electron microscopy of liposome attached to actin bundle [62] 
 
The transportation of liposomes and E. coli cells were investigated using in vitro motility 
assays with F-actin and actin bundles. The results indicated that transportation of both samples 
were successful using actin bundles, however F-actin was able to transport liposomes but not E. 
coli cells. Also, F-actin/liposome complexes moved in random directions while actin 
bundle/liposomes indicated longer linear movement.  These results indicated that actin bundles 
had a higher cargo transport capability and longer linear and stable movement when compared to 
F-actin [62].  
3.4 Transportation of Actin-coated liposomes 
Another method investigated the usage of actin and myosin to transport cargo through a 
decorating sample approach. In particular, actin filaments were attached to positively charged 
liposomes and the motility of these complexes was investigated [63].  Figure 3.6 shows a 
liposome (1-3 µm) prepared by DOPC (neutral lipid) and DOTAP (cationic lipid) coated with 
actin filaments on HMM coated surface.  
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Figure 3.6 - Liposome coated actin filaments on HMM motor proteins [63] 
 
The actin-coated liposomes showed straight movement on HMM covered surface; 
however the velocity of liposomes was considerably reduced when compared to the velocity of 
control actin filaments. This effect may be caused by limited interaction of actin filaments with 
myosin since non-specific attachment of liposomes to the surfaces might occur. The distance 
traveled was also dependent upon the percentage of DOTAP used for preparation of the 
liposomes. When 100% DOTAP was used, the liposomes traveled a shorter distance than when 
30% DOTAP was used. This effect might be due to the excessive positive charge of liposomes 
that could have possibly resulted in different arrangement and orientation of actin filaments on 








Chapter 4 Experimental Process 
In this chapter an overview of the experimental process is provided. The details of the 
methods and materials used for each experiment are given further, in Chapter 5. 
4.1 MWCNTs and G-actin 
4.1.1 Experiment: Investigate the effect of DI water and G-buffer on MWCNTs.   
The experiment determines the dispersion of MWCNTs in different solvents.  In 
particular, upon performing a visual inspection, a more rigorous analysis was conducted by 
performing a solubility test to quantify the differences in dispersity of the MWCNTs in DI water 
and G-actin buffer (G-buffer) respectively.  Dispersity was calculated based on the amount 
suspended in both solvents and the initial starting amount. 
4.1.2 Experiment: Investigate the attachment of actin monomers onto MWCNTs.   
The hypothesis tested was whether or not actin monomers attach to the hydrophobic 
CNTs.  The amount of proteins added to the solution of MWCNTs was calculated based on the 
available surface area of the MWCNTs and surface area of actin monomers. After adding the 
proteins to MWCNTs solution, the amount of proteins attached and immobilized on the 
MWCNTs were calculated based on the difference between the initial amount and the amount 
that of free protein (unbound) washed out. The protein concentration was measured using Optical 
Density (OD) value of G-actin as well as the BCA protein assay kit.  
MWCNTs/G-actin and MWCNTs (control) in G-buffer were visually compared to 
observe dispersion of MWCNTs in both conditions. To further confirm the attachment of actin 
monomers onto the MWCNTs, the MWCNT/G-actins conjugates were analyzed using AFM.  
4.1.3 Experiment: Investigate the functionality of MWCNT-G-actin conjugates.   
The functionality of immobilized G-actin (i.e. G-actin immobilized onto MWCNTs) was 
compared with the functionality of free G-actin in solution. In the cell G-actin polymerizes to F-
actin, a major component of the cellular cytoskeleton [20]. If the immobilized G-actin is still 
functional onto the MWCNTs support, it is expected that with the addition of free G-actin, the 
immobilized G-actin will polymerized onto MWCNTs scaffolds to lead to hybrid assemblies. 
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Briefly, the functionality of the immobilized G-actin was tested by adding free G-actin to the 
MWCNT-G-actin conjugates. The resulting hybrids were labeled with rhodamine-phalloidin and 
investigated using optical microscopy. 
 
4.2 MWCNTs and F-actin 
Another set of experiments were conducted to determine the functionality of actin 
filaments on the surface of MWCNTs.  
4.2.1 Experiment: Investigate the functionality of the MWCNT-F-actin assemblies using 
antibody recognition. 
The functionality of the actin filaments was tested using antibodies. Anti-actin antibodies 
recognize and bind to actin filaments in solution. The presence of fluorescent beads attached to 
antibodies enables observation and detection of these interactions using fluorescent microscopy 
[55]. If the actin filaments are still functional, then incubation of antibody-coated beads with the 
structures of MWCNT-F-actin could result in the attachment of the beads to the actin filaments 
formed onto the MWCNTs scaffolds.  
   
4.2.2 Experiment: Investigate the functionality of the MWCNT-F-actin assemblies using 
gliding motility assay 
The functionality and movement of the MWCNT-F-actin hybrid assemblies were tested 
using gliding motility assays. In the gliding assay, the motors are fixed on the surface and in the 
presence of ATP the filaments glide on the myosin-coated surface [64]. The motility of 
MWCNT-F-actin assemblies was tested in the presence of ATP as the energy source, with the 
HMM-coated surface as the motor proteins to enable the movement. The actin filament and 
actin-bead motility assays were used as controls. 
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Chapter 5 Materials and Methods 
5.1 Materials and Chemicals 
In this chapter the materials and methods used for the experiments described in Chapter 4 
are mentioned.   
5.1.1 Chemicals 
Table 5.1 - Chemicals, manufacturer and part number 
Chemical Manufacturer  Product Number 
Adenosine Triphosphate (ATP) Sigma-Aldrich A2383 
Anti-mouse IgG fluorescent particles Spherotech Inc. MFP-0552-5 
Anti-pan actin monoclonal antibody Fisher Scientific MA1-37018 
BCA protein assay kit   Pierce 23227 
Biotin-XX phalloidin Invitrogen B7474 
Bovine Serum Albumin (BSA) Sigma-Aldrich A7906 
Calcium chloride (CaCl2) Fisher Scientific C77 
Catalase  Sigma-Aldrich C9322 
Collodion Ernest F. Fullam, Inc.  
DL-Dithiothreitol (DTT) Sigma-Aldrich D0632 
Fluorescent bead Spherotech Inc. SVFP-0552-5 
Glucose (D-(+)- Glucose)  Sigma-Aldrich G7528 
Glucose oxidase (GO) BioChemika 49182 
Imidazole Sigma-Aldrich I2399 
Magnesium chloride (MgCl2) Sigma-Aldrich M1028 
Potassium chloride (KCl) Fisher Scientific P217 
Rabbit muscle powder Pel-Freez Biologicals 41995 
Rhodamine-Phalloidin  Invitrogen R415 
Sodium bicarbonate (NaHCO3) Fisher Scientific BP328 




Table 5.2 - Device, manufacturer and model 
Device Manufacturer Model 
Centrifuge Fisher Scientific Sorvall legend  
Ultra-centrifuge  Fisher Scientific Beckmann 70Ti rotor  
Spectrophotometer Fisher Scientific BioMate 3  
Fluorescent Inverted microscope Nikon Eclipse TE200 
Fluorescent Inverted microscope Camera Hamamatsu Photonics C4742-80-12AG 
Atomic Force Microscope Asylum Research MFP-3d-Bio 
Scanning Electron Microscope JEOL JSM 7600F 
5.1.2.1 Fluorescent Inverted microscope 
A Nikon inverted fluorescent microscope (Nikon Eclipse TE200) was used to conduct the 
fluorescent microscopy experiments. Fluorescent microscopy is performed by shining light at a 
sample with a wavelength that matches the excitation wavelength of the sample. The two 
excitation filters used were: 
 
Table 5.3 - Fluorescent microscope filters 
Filter Model Excitation Wavelength  
(nm) 
Dichromatic Mirror 
Cut-on Wavelength (nm) 
Emission Wavelength  
(nm) 
B-2E/C 465-495 505 515-555 
G-2E/C 528-553 565 590-650 
 
The observation of F-actin was done using a 100xoil objective and the G-2E/C 
fluorescent filter. Figure 5.1 illustrates principles of a fluorescent microscope: 
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Figure 5.1 - Fluorescent Microscope, Wikimedia Commons 
 
The fluorescent microscope images were captured using a Hamamatsu Photonics digital 
camera model C4742-80-12AG which acquires images at a rate of 8.9 frames per seconds at a 
1344 x1024 pixel format. 
The microscope, computer interface, camera and power supplies are shown in Figure 5.2: 
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Figure 5.2 - Microscope and power supplies 
5.1.2.2 Image Recording 
5.1.2.2.1 Wasabi 
The images and videos were acquired using the Wasabi software (Version 1.5). The 
software allows the user to control the CCD exposure time, frame rate and screen size through a 
user interface. Other functions include processing images and videos, e.g. control of image 
contrast, tint and blending images with different fluorescent filters, converting image sequences 
to videos, etc. Figure 5.3 shows the Wasabi software user interface for tint and blend of images.  
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Figure 5.3 - Wasabi, tint and blend of images 
5.1.2.2.2 Image J 
Analyses of images obtained from fluorescent microscopy were performed using Image J 
1.45q. The software allows the user to conduct operations such as counting of elements, scaling 
images from pixels to units of length, tracking velocity of samples, etc. Figure 5.4 shows the 
Image J software user interface for manual tracking of particles. 
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Figure 5.4 - Image J, manual tracking of actin filaments 
 
5.1.2.2.3 VirtualDub 
Processing and editing of videos were done using VirtualDub 1.9.11. The software allows 
the user to perform tasks such as cutting videos, changing frame rate of desired videos and also 
converting videos to image sequences.  
5.1.2.2.4 Atomic Force Microscopy (AFM) 
AFM was performed using an Asylum Research Instruments MFP-3D-Bio with 
AC240TS tip microscope. For AFM, the samples were deposited on mica (0.1 mg/ml 




Figure 5.5 - AFM contact mode - Wikimedia Commons 
5.1.2.2.5 Scanning Electron Microscopy (SEM) 
Scanning electron microscopy was performed using a JEOL 7600F microscope. The 
samples (1 mg/ml concentration) were deposited on silica wafer and vacuum dried for 24 hrs. 
Figure 5.6 shows the schematic of an SEM: 
 
 
Figure 5.6 - SEM, Wikimedia Common 
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5.2 Methods  
5.2.1 Buffers 
• G-actin Buffer (G-buffer): 2mM Tris-HCl, 0.2mM ATP, 0.2mM CaCl2, 0.5mM DTT 
pH 8.0 
• Motility Buffer (M-buffer): 25mM KCl, 2mM MgCl2, 0.2mM CaCl2, 25mM Imidazole 
pH 7.0 
5.2.2 Protein Purification 
5.2.2.1 F-actin Purification [65]: 
1. Grind rabbit muscle acetone powder for 10mins 
2. Pour grinded powder into a microtube and mix with 5mL of 1M NaHCO3 for 10mins 
on ice to separate G-actin from powder 
3. Centrifuge the mixture at 4000 rpm for 10mins at 4ºC 
4. Decant the supernatant into an empty microtube and store on ice 
5. Add 5mL NaHCO3 into the microtube of step 2 and stir for 10mins on ice 
6. Centrifuge the mixture at 4000 rpm for 10mins at 4ºC 
7. Decant the supernatant into the microtube of step 4 
8. Centrifuge the mixture of supernatants at 4000 rpm for 10mins at 4ºC 
9. Decant the supernatant into an ultra-centrifuge container and centrifuge at 40000 rpm 
for 1 hour at 4ºC 
10. Decant the supernatant into an empty microtube and add 3M KCl with 100:1 (v/v) 
ratio (supernatant: KCl) to induce actin polymerization 
11. After 12 hours incubation at 4ºC, G-actin will polymerize into F-actin 
12. Centrifuge the solution at 40000 rpm for 1:30 hours at 4ºC 
13. Discard the supernatant, the pellet at the bottom is F-actin 





5.2.2.2 G-actin Purification 
5.2.2.2.1 Similar method described for F-actin 
1. Grind rabbit muscle acetone powder for 10mins 
2. Pour grinded powder into a microtube and mix with 5mL of 1M NaHCO3 for 
10mins on ice to separate G-actin from powder 
3. Centrifuge the mixture at 4000 rpm for 10mins at 4ºC 
4. Decant the supernatant into an empty microtube and store on ice 
5. Add 5mL NaHCO3 into the microtube of step 2 and stir for 10mins on ice 
6. Centrifuge the mixture at 4000 rpm for 10mins at 4ºC 
7. Decant the supernatant into the microtube of step 4 
8. Centrifuge the mixture of supernatants at 4000 rpm for 10mins at 4ºC 
9. Decant the supernatant into an ultra-centrifuge container and centrifuge at 40000 
rpm for 1 hour at 4ºC 
10. Add G-buffer to the supernatant and mix well, store at 4ºC 
5.2.2.2.2 Using the dialysis kit 
1. Inject the F-actin solution into a dialysis cassette  
2. Attach a float buoy and dialyze against G-buffer for 2 hours at 4ºC 
3. Change the buffer and dialyze for another 2 hours at 4ºC  
4. Change the buffer and dialyze over night at 4ºC 
5. Withdraw the dialyzed solution, now G-actin, and store at 4ºC 
5.2.3 Measuring Protein Concentration 
5.2.3.1 Optical Density Value 
1. Prepare different concentrations of protein: 5,10,20,40,80 times dilution 
2. Measure Optical Density (OD) values at 290nm wavelength using a 
spectrophotometer 
3. Compare the values with 0.633(OD value of 1mg/ml of F-actin and G-actin at 
290nm) to determine protein concentration 
5.2.3.2 BCA Protein Assay Kit 
1. Prepare different concentrations of protein: 5,10,20,40,80 times dilution 
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2. Prepare the working reagent (WR) by adding 50 parts of Reagent A to 1 part of 
Reagent B (both reagents are included in the assay kit) 
3. Add 50µl of protein solutions to 1mL of WR and incubate the mixture in a water 
bath at 60°C for 30mins 
4. Measure the absorbance of mixtures at 562nm using a spectrophotometer 
5. Create a standard curve using different concentrations and determine protein 
concentration 
Figure 5.7 illustrates different colors based on the concentration of protein, which can be 




Figure 5.7 - BCA protein assay 
5.2.4 G-actin to F-actin polymerization 
G-actin was polymerized into F-actin by addition of M-buffer to G-actin solution. 
Increasing the ionic strength by addition of KCl will also induce polymerization. Adding M-




Figure 5.8 - G-actin polymerizes into F-actin 
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5.2.5 F-actin Labeling and observation  
As mentioned before, phalloidin toxins from Amanita mushroom bind along actin 
filaments and prevent depolymerization. Fluorescent derivatives of phalloidin can be used to 
observe actin filaments using fluorescent microscopy [20]. Labeling of F- actin was performed 
using rhodamine-phalloidin or biotin-XX phalloidin with 1:1 ratio for fluorescence observation. 
Interaction of Biotin with streptavidin allows for attachment of biotin labeled F-actin 
(biotinylated F-actin) to streptavidin-coated beads and samples. The mixture was stored over 
night at 4ºC to allow uniform and complete binding before observation.  
F-actin was observed using anti-photo bleaching reagents and the fluorescent microscope. 
The solution contains: 1µl 250µg/ml labeled F-actin, 1µl 1000mM DTT, 1µl 21.6mg/ml Glucose 
Oxidase, 1µl 3.6mg/ml Catalase, 1µl 450mg/ml Glucose and 95µl M-buffer.  
5.2.6 Antibody and bead attachment onto F-actins 
Anti-actin antibodies (primary antibody) were incubated with actin filaments followed by 
addition of antibody-coated fluorescent beads (secondary antibody). 10µl 200µg/ml of anti-actin 
antibody was incubated with 10µl 250µg/ml labeled F-actin for 1hr. After an hour antibody 
coated fluorescent beads (0.1% w/v, 0.4-0.6µm) were added to the mix solution and incubated 
for another hour. Anti-photo bleaching reagents (1µl 150mM ATP, 1µl 1000mM DTT, 1µl 
21.6mg/ml Glucose Oxidase, 1µl 3.6mg/ml Catalase, 1µl 450mg/ml Glucose) were added to the 
solution. Figure 5.9 illustrates attachment of fluorescent beads to actin filaments through primary 
and secondary antibodies. 
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Figure 5.9 - F-actin-bead through primary and secondary antibodies 
5.2.7 Oxidation of CNTs 
Oxidized multi walled carbon nanotubes (MWCNTs) were prepared by adding 45 ml 
sulfuric acid (H2SO4) and 15 ml nitric acid (HNO3) to MWCNTs (100 mg, diameter (15±5) nm, 
length 5-20 µm, NanoLab, Newton, MA). The suspension was sonicated for 3 hrs at room 
temperature. The acid mixture was diluted in water (200 ml) and the solution was filtered 
through a 0.2µm filter membrane (Millipore, USA). This procedure was repeated six times to 
remove all the catalyst residues.  
5.2.8 Dispersion Test 
The MWCNTs (acid treated for 3 hrs) were dispersed in DI water (pH 6.25) and G-actin 
Buffer (pH 8) respectively. First, MWCNTs were diluted in the different solvents in individual 
vials to generate 1mg/ml solution. Next, 1 ml of the suspension was centrifuged at 3000 rpm for 
5 mins. Subsequently, part of the supernatant (0.8 ml) was removed and filtered through a 0.2 
µm GTTP membrane filter. After complete drying under vacuum, the amount of MWCNTs on 
the filter membrane was collected and measured. Dispersion was calculated based on the amount 
suspended and the initial starting amount. 
5.2.9 G-actin immobilization onto MWCNTs 
Actin monomers (G-actin) (5nM) were added to MWCNTs (250µg) in G-buffer. The 
amount was calculated using surface area of G-actin for interaction with CNTS. The mixture was 
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shaken for 2 hrs at 200 rpm and 4°C. Subsequently, the mixture was centrifuged for 5 mins at 
10,000 rpm, and the supernatant was collected. Finally, the mixture was washed 6 times to 
remove unbound protein, and the washes were also collected to help investigate the amount 
immobilized onto the MWCNTs as described below. Figure 5.10 illustrates the general 
procedure used to immobilize actin monomers onto CNTs. 
 
 
Figure 5.10 - Carbon nanotube incubation with actin monomers 
 
5.2.10 Calculation of G-actin loading onto MWCNTs 
The protein concentration of collected supernatant and washes was measured using the 
BCA protein assay kit. The working reagent was prepared by adding 50 parts of Reagent A to 1 
part of Reagent B (both reagents are included in the assay kit). Either supernatant, washes or 
control (50µl) was added to the working reagent (1ml) and the mixture was incubated in a water 
bath at 60°C for 30 mins. The absorbance of the mixture was measured at 562nm using the 
spectrophotometer. The standard curve was created using G-actin as the control. The loading of 
G-actin on MWCNTs was calculated based on the difference of initial amount of protein added 
and amount that was washed out or in the supernatant. 
5.2.11 Polymerization of G-actin on MWCNTs to F-actin  
For the polymerization process, MWCNT-G-actin conjugates were incubated with free 
G-actin (250µg/ml) for an hour at room temperature. The resulting structures were labeled with 
rhodamine-phalloidin and analyzed using fluorescent microscopy. Figure 5.11 illustrates the 
process of polymerization on the carbon nanotubes with addition of G-actin.  
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Figure 5.11 - Polymerization of G-actin to F-actin on CNTs 
5.2.12 Antibody and bead attachment onto CNT/F-actins 
Anti-actin antibodies (primary antibodies) were incubated with CNT/actin filaments; 
subsequently, antibody coated fluorescent beads (secondary antibodies) were added. 10µl 
200µg/ml anti-actin antibody was incubated with 10µl CNT/F-actin for 1hr. After an hour, 10µl 
antibody coated fluorescent beads (0.1% w/v, 0.4-0.6µm) was added to the mix solution and 
incubated for another hour. Anti-photo bleaching reagents (1µl 150mM ATP, 1µl 1000mM DTT, 
1µl 21.6mg/ml Glucose Oxidase, 1µl 3.6mg/ml Catalase, 1µl 450mg/ml Glucose) were added to 
the solution.  
5.2.13 Motility Assays 
5.2.13.1 F-actin motility assay 
The F-actin solution used for motility included F-actin and anti-photo bleaching reagents; 
ATP was added to the solution to induce actin motility. The solution contains: 1µl 250µg/ml 
labeled F-actin, 1µl 150mM ATP, 1µl 1000mM DTT, 1µl 21.6mg/ml Glucose Oxidase, 1µl 
3.6mg/ml Catalase, 1µl 450mg/ml Glucose and 94µl M-buffer. 
1. Coat the surface of a cover slip with 0.2% collodion and bake in oven for 
30minutes at 75°C. 
2. Make a flow chamber using the collodion covered cover slip. 
3. Add HMM (200 µg/ml) to the flow cell and wait 5 minutes for the HMM to attach 
to the surface. 
4. Add BSA (1 mg/ml) and wait for 5 minutes to prevent non-specific binding of F-
actin.  
5. Wash with M-buffer to remove unattached HMM and BSA. 
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6. Add F-actin solution and record the movement and motility. 
 
Figure 5.12 shows the behavior and movement of actin filaments in the presence of ATP 
and HMM in the gliding motility assay. 
 
 
Figure 5.12 - Actomyosin motility assay 
5.2.13.2 Bead motility assay 
Actin filaments are attached to beads using streptavidin coated beads (fluorescent bead) 
and biotinylated F-actin. 1µl fluorescent bead (0.1% w/v, 0.4-0.6µm) was added to 93µl M-
buffer and sonicated for 1min to spread beads evenly in M-buffer. This increased the dispersion 
of beads and attachment to biotinylated F-actin. F-actin and anti-photo bleaching reagents were 
added to the solution. The final solution contains: 1µl fluorescent bead, 1µl 250µg/ml labeled F-
actin, 1µl 150mM ATP, 1µl 1000mM DTT, 1µl 21.6mg/ml Glucose Oxidase, 1µl 3.6mg/ml 
Catalase, 1µl 450mg/ml Glucose and 93µl M-buffer. 
After 30 minutes the motility procedure was conducted. The motility procedure was 
similar to the F-actin motility assay with the difference of adding the F-actin/bead mix in the last 
step (step 6). Figure 5.13 shows the attachment of beads to actin filaments through streptavidin 
and biotin interactions as well as the motility assay. 
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Figure 5.13 - Actin-bead motility assay 
 
5.2.13.3 CNT/F-actin motility assay 
The procedure was similar to F-actin motility assay with the only difference being the 
addition of CNT/F-actin hybrids in the last step (step 6). 
5.2.14 Cleaning Cover slips 
The cover slips were cleaned before experiments to ensure removal of dirt and unwanted 
particles. 
1. Put cover slips in a Petri dish and fill with detergent and DI water 1:20, sonicate for 5 
minutes 
2. Put cover slips in another Petri dish filled with DI water and sonicate for 5 minutes 
3. Rinse with acetone under sonication 
4. Rinse with 2-propanol under sonication 
5. Rinse with DI water under sonication 
6. Dry the cover slips for 5 minutes in oven at 75°C 
5.2.15 Flow Chamber 
The optical microscopy experiments were performed in a 100µm thick flow chamber. 
The flow chamber was assembled using a microscope slide (Corning micro slides) and a glass 
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cover slip (Corning cover glass, 18×18 mm2) that was separated using double-sided tape. The 
samples were perfused in the space created and observed under the microscope. 
 
 




Chapter 6 Results and Discussions 
6.1 F-actin observation 
Actin filaments were observed using fluorescence microscopy.  Figure 6.1 shows the actin 
filaments at a concentration of 2.5 µg/ml in M-buffer:  
 
Figure 6.1 - Fluorescent actin filaments (F-actin) 
 
The surface shows non-specific attachment of filaments on the cover slip. However, some 
of the actin filaments, which are not fully attached on the surface, exhibit a “diffuse” end and 
Brownian motion. A number of these filament ends are shown in Figure 6.1. Better observation 
and full attachment of the actin filaments on the surface were achieved using Poly (Diallyl 
Dimethyl Ammonium Chloride) (PDDA). PDDA creates a sticky surface due to long amino 
chains [66], and enables non-specific attachment of actin filaments. The cover slips were placed 
in 1% (v/v) of PDDA and DI water for a time duration ranging from 30mins to 1hr, followed by 
rinsing and drying for removal of excess PDDA.  
Figure 6.2 shows F-actin attached on the surface covered with PDDA. The results 
indicate that the average length of F-actin was between 15±5 µm, which is consistent with prior 




Figure 6.2- Fluorescent actin filaments on PDDA-coated surface 
 
6.1.1 Acid treated MWCNTs  
The Scanning Electron Microscopy (SEM) images below shows the acid treated 
MWCNTs that were used for the experiments. The image on the left is magnified 20,000 times, 
while the one on the right is magnified 50,000 times.  
 
 
Figure 6.3 - Acid treated MWCNTs 
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6.2 MWCNTs and G-actin 
6.2.1 MWCNTs in G-actin Buffer (G-buffer) 
The dispersion of MWCNTs in G-buffer was investigated and compared with MWCNTs 
in water (control). The visual inspection of the two samples did not reveal any major differences 
in the dispersion. Figure 6.4 shows both samples. The sample on the left is MWCNTs in G-
buffer and the sample on the right shows dispersion of MWCNTs in water. 
 
 
Figure 6.4 - MWCNTs in G-buffer on left and MWCNTs in water on right 
 
The dispersion test showed however that there was a higher dispersion ratio of the 
MWCNTs in G-buffer- by a factor of 1.25- when compared with dispersion of the MWCNTs in 
water. This was due to the different pH condition that the two dispersants have, i.e. DI water (pH 
6.25) and G-buffer (pH 8). Similar results were observed in [68] for solutions with different pH 
condition. The formation of carboxyl groups on the surface of MWCNTs influences the 
solubility in different solvents. Addition of acid treated MWCNTs to solvents leads to 
deprotonation of the carboxylic acid groups. Higher pH values of dispersants result in higher 
degree of deprotonation. This produces more carboxylate anions that repel each other [69], 
which increases solubility of the MWCNTs.  
6.2.2 Attachment of G-actin to MWCNTs 
Next, the attachment of G-actin onto MWCNTs dispersed in G-buffer was investigated. 
The resulting MWCNT-G-actin conjugates and MWCNTs in G-buffer are shown in Figure 6.5. 
The sample on the left illustrates the MWCNT-G-actin conjugates, while the sample on the right 
shows the MWCNTs dispersed in G-buffer.  
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Figure 6.5 - G-actin attached to MWCNTs on left and MWCNTs in G-buffer on right 
 
Visual inspection of the samples shows that the conjugates solution tends to form 
conglomerates when compared with the control (MWCNTs dispersed in G-buffer). 
Conglomerates formation is a result of the hydrophobic- hydrophobic interactions of the 
individual MWCNT-G-actin conjugates, with strong hydrophobic interactions being formed 
between G-actin (pI 5.23) and the hydrophobic MWCNTs dispersed in G-buffer during the 
incubation time. 
6.2.3 Observing MWCNTS using DIC and fluorescent microscopy 
A fluorescent microscope was used to observe G-actin covered samples. As mentioned 
earlier, chapter 5, rhodamine-phalloidin has F-actin binding sites, which stabilizes polymerized 
actin monomers and prevents depolymerization. Labeling these conjugates resulted in 
observation of actin monomers aggregates and short filaments. In Figure 6.6 the top left image 
(A) illustrates bundles of CNTs using the Differential Interference Contrast (DIC) of the 
microscope. The top right image (B) illustrates G-actin aggregates on CNTs using a fluorescent 




Figure 6.6 - A) MWCNT B) G-actin C) MWCNT/G-actin 
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6.2.4 Atomic Force Microscopy (AFM) for observation of G-actin 
AFM was used to confirm the attachment of G-actin to CNTs. There is close to full 
coverage of the MWCNTs by G-actin protein (diameter of 5nm [70]) as illustrated in Figure 6.7 
when compared with control MWCNTs. The arrow indicates presence of proteins on CNTs. By 
comparing the diameters of carbon nanotubes in both images coverage of CNTs with protein was 
determined. The lower image in both figures is magnified to further illustrate the morphology of 
CNTs with and without proteins respectively. 
 
 
Figure 6.7 - AFM image of G-actin/CNTs (Left), AFM image of CNTs in G-buffer (Right) 
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6.3 MWCNTs and F-actin 
6.3.1 Functionality of MWCNT–G-actin conjugates 
The functionality of immobilized G-actin was investigated to determine whether addition 
of free G-actin would lead to F-actin- based structures with MWCNTs as scaffolds.  
The resulting structures were labeled with rhodamine-phalloidin and analyzed using 
fluorescent microscopy. Part A of the image shows the Differential Interference Contrast (DIC) 
image of MWCNT-G-actin conjugates polymerized with free G- actin, while part B shows 
fluorescent images of actin filaments on CNTs. Lastly, C illustrates a merged image of 
MWCNTs and F-actin indicating the co-localization of actin filaments with the MWCNTs. 
These preliminary results indicated F-actin filament formation onto MWCNT-scaffolds, thus 
creating the so-called “smart” hybrids. 
 
  
Figure 6.8 - A) MWCNT B) F-Actin C) MWCNT/F-actin 
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6.3.2 Functionality of MWCNT-F-actin hybrid assemblies 
6.3.2.1 Recognition of MWCNT-F-actin assemblies using antibody 
The recognition capability of MWCNT-F-actin assemblies using antibodies was also 
investigated. To ensure proper control, attachment of antibodies to individual actin filaments was 
tested first. Briefly, anti-actin antibodies (primary antibodies) were incubated with actin 
filaments, followed by addition of antibody-coated fluorescent beads (secondary antibodies). The 
image below (Figure 6.9) on the left indicates attachment of fluorescent beads (secondary 
antibodies) to actin filaments in the presence of the primary antibody. The image on the right is 
the control without the presence of the primary antibody, thus indicating beads are not attached 
to the actin filaments.  
 
 
Figure 6.9 - Primary and secondary antibody (Left), secondary antibody (control) (Right) 
 
After confirming attachment of fluorescent beads to actin filaments through the primary 
antibody, recognition of the antibodies to F-actin on the surface of CNTs was investigated and 
compared with fluorescent beads without the presence of the primary antibody (control). The 
number of beads indicates dependence upon the conglomerate and its size. The preliminary 
results indicate that the number of beads on the surface of the CNTs is on average 5 times greater 
when using the primary antibody (N=36). These 36 samples were collected from 10 flow cells 
and 5 separate experiments performed over 3 days. The number of beads was counted using the 
Image J “Analyze Particles” function. The results confirm recognition of the actin filaments on 
MWCNTs using anti-actin antibodies. 
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Figure 6.10 - A) MWCNTs B) Primary and secondary antibodies C) Merged image of A and B 
 
Figure 6.11 - A) MWCNTs B) Secondary antibodies C) Merged image of A and B 
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The images below (Figure 6.12 and 6.13) confirm the same results. Unlike the prior 
experiment, a higher concentration of beads (5 times) was used to determine if the antibodies 
recognized the actin filaments. Once again based on the preliminary results, a higher number of 
beads attached to the surface (on average 10 times) when using the primary antibody (N=24). 
These 24 samples were collected from 8 flow cells and 4 separate experiments performed over 2 
days.   
  
 




Figure 6.13 - A) MWCNTs B) Primary and secondary antibodies C) Merged image of A and B 
 
6.3.2.2 Motility of MWCNT-F-actin hybrid assemblies 
As mentioned in 6.3.2.1, the functionality of the assemblies was tested using antibodies 
to investigate whether they were able to recognize the actin filaments formed by polymerization 
of free actin onto the actin immobilized onto the carbon nanotube surfaces. However, attachment 
of limited number of beads was observed without the presence of the primary antibodies. The 
beads may have attached to non-functional actin filaments created on the surface of the 
MWCNTs non-specifically, which also resulted in non-specific attachment of the secondary 
antibodies. To further confirm functionality of the filaments, motility of these hybrid assemblies 
was also investigated.  
 
6.3.2.2.1 Actomyosin motility assay 
In the first step, motility of actin filaments and velocities were quantified. The averages 
of velocities indicate that the ambient temperature affects the velocity. This is caused by the 
dependence of ATPase rates to temperature [71]. Experiments were performed at different 
temperatures (20ºC and 25ºC). The results are shown as mean ± SEM (Standard Error of Mean). 
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The average velocities at 20ºC and 25ºC are 0.83±0.03 µm/s (N=30) and 1.27±0.07 µm/s (N=50) 
respectively. The samples were collected from 15 flow cells and 5 separate experiments 
performed over 4 days. Based on the results the room temperature was kept between 25ºC and 
26ºC for the remainder of the experiments. The measured values are presented in Figure 6.14.  
 
 
Figure 6.14 - Average velocity of actin filaments 
 
The actin filaments indicated lower velocity at 20ºC when compared to F-actin at 25ºC. 
To determine if the difference in average velocity between the two values was statistically 
significant the Welch’s t-test was used. The following hypotheses were also tested: 
NULL: There is no difference in the average velocity for both samples 
ALT: The average velocity for F-actin at 25ºC is higher than F-actin at 20ºC 
The NULL hypothesis is strongly rejected with P≤0.005, indicating that the F-actin at 
25ºC exhibited significantly higher velocity. 
6.3.2.2.2 Actin-bead motility assay 
Movement and velocity of beads attached to actin filaments were investigated to 
demonstrate the ability of transporting carbon nanotubes using actomyosin motility assays. The 
successful attachment of streptavidin-coated beads onto biotinylated actin filaments is shown in 























F-actin at 20°C 
F-actin at 25°C 
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to the high concentration of streptavidin on beads (1.69×104 streptavidin/particle) and interaction 
with biotin on the filaments.   
 
 
Figure 6.15 - Biotinylated actin filaments and beads (Left), actin filaments and beads (Right) 
 
The motility of beads attached to actin filaments on HMM coated surface was 
investigated. The images below (Figure 6.16,Figure 6.17) show movement and gliding of the 
beads on HMM coated surfaces at 1second intervals. 
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Figure 6.16 - Actin-bead motility assay 
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Figure 6.17 - Actin-bead motility assay 
 
The velocities of beads were compared with unloaded actin filaments. The average 
velocities of actin filaments with beads and without beads at 25°C are 1.06±0.1 µm/s (N=33) and 
1.25±0.08 µm/s (N=67) respectively. The samples were collected from 15 flow cells and 5 




Figure 6.18 - Average velocity of loaded and unloaded actin 
 
The F-actin- beads indicated lower velocity when compared to single actin filaments. To 
determine if the difference in average velocity between the F-actin with and without bead was 
statistically significant the Welch’s t-test was used and the following hypotheses were tested: 
NULL: There is no difference in the average velocity for F-actin with and without beads 
ALT: The average velocity for F-actin without beads is higher 
The NULL hypothesis is strongly rejected with P≤0.05, indicating that the F-actin 
without beads exhibited significantly higher velocity. 
Addition of higher number of beads (higher concentration) further disabled the actin 
motility. This may be due to the attachment of beads through biotin-streptavidin interaction onto 
actin filaments, and blocking interaction of filaments with myosin motors. Similar results were 
observed when increasing the number of quantum dots added onto actin filaments [72], causing 
significant blocking of actin and myosin interactions.  
6.3.2.2.3 CNT-F-actin hybrid assembly motility 
Movement and velocity of CNT-F-actin hybrids was investigated to demonstrate 
functionality of actin filaments attached on the surface of carbon nanotubes. The images below 
(Figure 6.19) indicate displacement and limited movement of CNT-F-actin assemblies after 5 



























Figure 6.19 - MWCNT-F-actin hybrid assemblies on HMM 
 
 Figure 6.20 indicates another sample of CNT-F-actin assemblies after 10 seconds. The 
hybrid assemblies indicate irregular movement and fluctuation with velocity of 1.03 µm/s. The 
results presented herein are preliminary, and should be further investigated in future experiments 




Figure 6.7 - MWCNT-F-actin hybrid assemblies on HMM 
 
The correlation between the size and radius of the carbon nanotubes and drag force 
associated with these nanotubes was investigated. The drag force caused by spheres can be 
calculated based on the following equation, where η is the viscosity of the medium, R and V are 
the radius and velocity of the sphere respectively:    
F= (8 π/3) η R V [64] 
The drag force of beads with diameter of 400-600 nm through a solution with viscosity of 
water (~1 mPa.s) is ~3.5-5 fN and for CNT aggregates with diameter of 10-30 µm is ~85-250 fN. 
These values indicate that a single myosin head is able to produce higher force (3-4 pN [73]). 
Multiple motors interact with individual actin filaments and large particles should be transported. 
However, a high number of the agglomerates showed very limited displacement or movement. A 
few of the hybrid assemblies indicate fluctuation, however the displacement was observed for a 
very short period of time and no movement was detected after that time period. These results 
may be caused by the inability of the myosin motors to recognize polarity of actin filaments 
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formed on the carbon nanotubes. Sideway movements of CNT and microtubule hybrid 
assemblies were also observed in previous studies [58].  
Attachment of the filaments on the carbon nanotubes surfaces may also cause steric 
hindrance of myosin. This is due to the direct attachment of large surface of actin filaments onto 
the nanotubes, and therefore prevents the attached filaments from interacting with myosin motors 
[74]. The length of actin filaments polymerized on the surface could also introduce another 
limiting factor in particular by the inability of myosin motors to move and interact with short 
actin filaments present on the surface of the carbon nanotubes. The actin filaments moving on 
myosin motors require continuous interaction with myosin heads to stay associated with the 
surface and also for each head to release and attach to the moving filaments [75]. The observed 
results may also be due to different arrangement and orientation of actin filaments on the 
MWCNT agglomerates, and thus the disabling unidirectional movement of such agglomerates. 
Similar results were observed for movement of actin-coated liposomes [63].  
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Chapter 7 Conclusions and Outlook 
The results of this research indicate that actin monomers (G-actin) attach to MWCNT. 
The AFM images showed close to full coverage of the MWCNTs by G-actin protein. The 
attached G-actins were also functional and polymerized into actin filaments on MWCNTs 
scaffolds. Specific antibodies were able to recognize the actin filaments on the surface of carbon 
nanotubes. These preliminary results are envisioned to be useful for future biosensor applications 
with the protein acting as an agent for specific detection [16].  
The motility of CNT-F-actin hybrid assemblies was also investigated on HMM-coated 
surface. A large number of the assemblies showed limited or no movement. These results may be 
caused by several factors and reasons: inability of the myosin motors to recognize polarity of 
actin filaments, limited interaction of the actin filaments with myosin due to direct interaction 
with MWCNTs, polymerization of short actin filaments on the surface of the nanotubes and 
different arrangement and orientations of actin filaments.  
Further investigation of the MWCNT-F-actin could be performed using Scanning 
Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM) [76]. These methods 
may allow visualization of the morphology of the MWCNT-F-actin hybrid assemblies.  
The same experiments could be done using SWCNTs due to their smaller diameter, and 
pristine (without acid treatment) MWCNTs to compare the results and further investigate 
interaction of actin with CNTs.   
The motility of the biohybrids could also be tested using processive myosin (e.g. myosin	  
V) instead of non-processive myosin (e.g. myosin II). Processive myosin remains attached to 
actin filaments [61] and may enable detectable movement of the hybrid assemblies.   
The movement of carbon nanotubes using myosin motors can also be investigated using 
bio-linkers such as streptavidin and biotin to attach actin filaments onto carbon nanotubes. This 
method would be achieved in a manner similar to streptavidin-coated beads and biotinylated 
actin.  Using a linker to attach and combine these nanomaterials may also enable longer travel 
distance and movement of the assemblies. Transportation of the biohybrids using ATP as the 
energy source and myosin motor proteins may facilitate possible solutions for transportation of 
biological and non-biological samples to specific locations. 
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